Invesco

Matalan is a British fashion and homeware retailer based in Knowsley, United Kingdom.

Asia Dragon Trust PLC is an investment trust based in the United Kingdom that specializes in providing investors access to reputable businesses in the Far East, excluding Japan and Australasia. The company aims for long-term capital growth by investing primarily in large, attractively priced companies across a diverse range of sectors, including Aerospace and Defence, Banks, Automobiles, Construction Materials, Industrial Conglomerates, Real Estate Management and Development, and Wireless Telecommunication Services. Asia Dragon Trust measures its portfolio performance against the MSCI All Country Asia (ex-Japan) index, reflecting its commitment to strategic and diversified investments in the region.

Caredoc is a platform dedicated to elderly care, designed to facilitate the connection between consumers seeking reliable care services and providers offering these services. The platform addresses the challenge of information accessibility, as families often struggle to find accurate details about elderly care facilities online or through informal channels. By providing verified information about care service providers, Caredoc enhances transparency and trust in the selection process. Additionally, it features quick matching functions and detailed caretaker profiles, allowing families to easily search for various clinics, hospitals, and doctors based on their specific needs, complete with reviews and ratings. This comprehensive approach helps streamline the search for quality elderly care, benefiting both families and care providers.

Franklin Energy Services, LLC is a company that specializes in designing and implementing customized energy efficiency programs for utilities, municipalities, and government bodies. Founded in 1989 and based in Port Washington, Wisconsin, it serves a diverse range of sectors including residential, multifamily, education, small businesses, agriculture, and commercial and industrial markets. The company provides various services such as trade ally management, rebate processing, engineering solutions, marketing, and customer care. Franklin Energy is recognized for its expertise in program administration and implementation, focusing on solutions that promote the efficient consumption of electricity and natural gas. This helps clients reduce energy consumption and achieve lower operating and maintenance costs. Franklin Energy Services was previously known as Schueller Energy Consultants before changing its name in January 1994.

Mynd is a technology-driven property management company specializing in single-family rental properties. It offers a suite of services, including property marketing, tenant screening, rent collection, maintenance, and accounting, to help investment property owners efficiently manage their assets and maximize returns. The company leverages technology and data analytics to enhance property performance, ensure timely communication, and provide property owners with real-time information and financial reports via its digital platforms.

Flowcarbon is a New York-based company founded in 2021 that specializes in carbon token technology aimed at accelerating decarbonization through nature-based climate initiatives. The company develops a system where premium, nature-based carbon credits are token-backed on a one-to-one basis. Flowcarbon focuses on renewable energy projects that not only optimize environmental benefits but also prioritize climate mitigation, support local and indigenous communities, and protect biodiversity. By offering world-class project finance, technology, project development, and credit portfolio services, Flowcarbon enables businesses to effectively manage their carbon offsets and promote sustainable practices while contributing to positive environmental and social impacts.

GeNeuro is a clinical-stage biotechnology company based in Plan-Les-Ouates, Switzerland, specializing in the development of therapeutic drugs for diseases linked to the expression of pathogenic proteins derived from human endogenous retroviruses. The company primarily targets nervous system disorders, including multiple sclerosis and schizophrenia. Its lead product, GNbAC1, is a therapeutic monoclonal antibody aimed at treating multiple sclerosis, while temelimab, another candidate, neutralizes a pathogenic protein associated with the HERV-W family. In addition to its therapeutic developments, GeNeuro also focuses on creating diagnostic tests to measure multiple sclerosis-associated retrovirus-ENV proteins in patients. Founded in 2006, GeNeuro is committed to addressing the underlying causes of neurodegenerative and autoimmune diseases.

Copper Banking is a financial education platform designed to empower teenagers with essential money management skills and financial literacy. Founded with the goal of providing real-world financial experiences, it offers a mobile app and debit card that allow teens to manage their finances in a supervised environment. The platform facilitates money transfers, direct deposits, and payments, making it easy for users to engage in everyday transactions. Additionally, Copper Banking connects parents and teens, fostering discussions around financial responsibility. Users benefit from exclusive content curated by financial literacy experts, who provide valuable insights and advice to help them make informed financial decisions and work towards achieving financial independence.

Capchase Inc. is a fintech company that provides an online platform enabling Software as a Service (SaaS) companies to access cash tied up in future monthly payments. Founded in 2020, Capchase allows these companies to finance their growth by converting accounts receivable into immediate capital. Utilizing advanced underwriting algorithms, the company assesses the value of contracts and offers lines of credit tailored to the needs of its clients. This innovative approach allows SaaS businesses to receive revenue upfront while maintaining the ability to collect monthly payments from their customers, facilitating rapid growth without resorting to equity dilution or costly financing methods. Capchase is headquartered in New York, United States.

Swiggy is an on-demand food delivery platform that connects customers with local restaurants, allowing them to order meals conveniently through a user-friendly app. The platform provides a comprehensive listing of nearby restaurants and their menus, enabling users to place orders and track deliveries in real-time. In addition to food delivery, Swiggy has expanded its services to include the pickup and drop-off of various items, such as laundry and documents, catering to both individual and business clients. By offering timely deliveries and promotional discounts, Swiggy aims to enhance the customer experience and ensure that meals are delivered fresh and promptly.

Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.

Pine Labs is a technology and financial solutions provider focused on enhancing merchant operations and increasing revenue. The company offers a comprehensive platform that facilitates both online and offline transactions, enabling retailers to connect with financial institutions and consumer brands efficiently. Its services include processing easy monthly installment transactions, delivering customer insights for targeted sales, and simplifying payment acceptance. Pine Labs supports over 350,000 POS terminals across 3,700 cities in India and Malaysia, catering to more than 100,000 merchants in diverse sectors such as electronics, food and beverage, fashion, and airlines. The company collaborates with 15 major banks and 7 financial institutions, ensuring a robust ecosystem for retailers to engage and retain customers while minimizing operational complexities and risks.

Aumni is a data-driven investment analytics platform based in the United States, focusing on private capital markets, which include venture funds, family offices, university endowments, and corporate venture firms. Founded by former corporate attorneys Tony Lewis and Kelsey Chase in Salt Lake City, Utah, Aumni leverages a combination of artificial intelligence and human expertise to extract and analyze critical deal data from complex legal agreements. The platform provides strategic insights into the economic positions and legal rights of investors, converting intricate deal data into a comprehensive and accurate dataset. By auditing and analyzing every transaction, Aumni enables investors and venture firms to make informed decisions, having already analyzed a vast array of private capital data linked to over $1 trillion in assets under management.

Abogen Biosciences, established in 2019 and headquartered in Jiangsu, China, specializes in the development of nucleic acid-based therapeutics, including RNA and DNA treatments, for combating cancer and infectious diseases.

Mynd is a technology-driven property management company specializing in single-family rental properties. It offers a suite of services, including property marketing, tenant screening, rent collection, maintenance, and accounting, to help investment property owners efficiently manage their assets and maximize returns. The company leverages technology and data analytics to enhance property performance, ensure timely communication, and provide property owners with real-time information and financial reports via its digital platforms.

Brii Biosciences Limited is a biotechnology company focused on the research, development, and commercialization of innovative medicines for chronic and infectious diseases, including hepatitis B virus (HBV), human immunodeficiency virus (HIV), and multi-drug resistant infections. Founded in 2018, the company is headquartered in Durham, North Carolina, with additional offices in Shanghai, Beijing, and San Francisco. Brii Biosciences aims to enhance healthcare outcomes for patients in China by leveraging advanced technology and data. The company has established strategic partnerships with organizations such as AliHealth and Vir to further its mission. With a robust pipeline consisting of over 10 product candidates, Brii Biosciences is dedicated to addressing significant public health challenges both in China and globally, focusing on delivering better treatments and cures for life-threatening diseases.

Godrej Properties brings the Godrej Group philosophy of innovation and excellence to the real estate industry. Each Godrej Properties development combines a 119-year legacy of excellence and trust with a commitment to cutting-edge design and technology. Godrej Properties is currently developing residential, commercial and township projects spread across 10.3 million square meters (111 million square feet) in 12 cities.

Nubank is a prominent digital bank revolutionizing finance with its customer-centric approach. It provides a variety of services, including credit cards, personal loans, and digital payments, all accessible through a simple mobile app. Known for transparency, ease of use, and low fees, Nubank aims to empower users with innovative solutions for better financial management.

Expert.ai is a developer of enterprise natural language processing technologies that focuses on transforming language-intensive processes into actionable insights. The company's platform combines symbolic human-like understanding with machine learning, enabling organizations to enhance decision-making and streamline operations. Expert.ai offers a range of solutions, including Cogito Discover, which utilizes artificial intelligence for analytics, extraction, and categorization of text across various formats, thus facilitating automation. Additionally, the Clinical Research Navigator assists biomedical clients in advancing research into therapies for infectious diseases. The company provides its services through on-premise, private, and public cloud offerings, catering to diverse industries such as insurance, banking, publishing, defense, and life sciences.

Clarkson PLC, established in 1852, is a global provider of integrated shipping services. It operates through four divisions: Broking, Financial, Support, and Research. The Broking segment facilitates transportation of various cargoes and handles sale and purchase transactions. The Financial segment offers investment banking services, structured finance, and freight derivatives. The Support segment provides port agency, freight forwarding, and marine supplies. The Research segment offers shipping data, analysis, and publications, serving clients in finance, government, insurance, and shipbuilding sectors. Clarkson PLC is headquartered in London, UK.

Intelliflo Redblack is a financial technology company that specializes in providing intuitive software solutions for registered investment advisors (RIAs) and family offices. The company’s platform facilitates rebalancing and trading, enabling firms to enhance their operational efficiency and deliver greater value to their clients. Intelliflo Redblack's software integrates seamlessly with existing technology systems, offering a comprehensive suite of capabilities including portfolio monitoring, pre-trade and post-trade compliance, and order management. By streamlining these processes, the platform allows advisors to achieve superior precision and personalization, ultimately supporting business growth and value creation.

Grab Holdings Inc., headquartered in Singapore, operates a mobile technology platform that integrates city transportation and various on-demand services in Southeast Asia. The company, founded in 2012 by Anthony Tan and Tan Hooi Ling, offers services such as ride-hailing (GrabTaxi, GrabCar), carpooling (GrabHitch, GrabShare), shuttle services (GrabShuttle, GrabShuttle Plus), and food delivery through its GrabFood platform. Grab also provides financial services, including payments, consumer loans, and enterprise offerings. It operates in eight countries: Singapore, Indonesia, Philippines, Malaysia, Thailand, Vietnam, and Myanmar. Grab generates revenue by charging commissions to both consumers and service providers, with ride-hailing and food delivery contributing to 89% of its total revenue. The company competes with Foodpanda and Gojek in the region.

Evofem Biosciences is a biopharmaceutical company based in San Diego, California, focused on addressing unmet needs in women's sexual and reproductive health. The company has developed Phexxi, the first and only hormone-free prescription vaginal gel approved in the United States for pregnancy prevention. In addition to Phexxi, Evofem is also working on EVO100, a vaginal pH regulator aimed at preventing the urogenital transmission of Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. Through its innovative products, Evofem Biosciences aims to enhance reproductive health care options for women.

OppenheimerFunds, Inc. is a privately owned investment manager established in 1959, based in New York City with additional offices in Rochester, London, Salt Lake City, and Centennial. The firm provides a comprehensive range of investment services, including asset management, retirement planning, mutual funds, separately managed accounts, and investment management for institutions. It serves a diverse clientele comprising financial advisors, individual investors, corporations, and endowments. OppenheimerFunds focuses on launching and managing equity, fixed income, balanced, multi-asset mutual funds, and hedge funds, employing fundamental analysis and external research to guide its investment strategies. The firm invests across public equity, fixed income, and alternative markets globally. As of May 24, 2019, OppenheimerFunds operates as a subsidiary of Invesco Ltd.

Intelliflo Ltd. is a provider of web-based business management software tailored for the financial services sector in the United Kingdom. Founded in 2004 and based in Kingston-upon-Thames, the company offers its flagship product, Intelligent Office, which serves a diverse clientele, including financial advisers, mortgage advisers, and service providers. This platform encompasses a wide range of features such as client management, financial planning, task management, compliance, and document management, enhancing operational efficiency for its users. Additionally, Intelliflo provides tools for investment research and portfolio monitoring through its FE Analytics module. The company aims to simplify the advisory experience by leveraging open software architectures and continuously evolving its technology to meet the needs of over 30,000 financial professionals worldwide, thereby supporting over three million end-investors. Through its comprehensive solutions, Intelliflo seeks to widen access to financial advice and improve the overall efficiency of financial advisory practices.

Alfred Club, Inc. is a technology-driven company that provides a resident experience and building management platform designed for apartment buildings. Founded in 2013 and based in New York, Alfred offers the Hello Alfred program, which allows residents to outsource everyday tasks such as package receiving and dog walking to dedicated home managers. These home managers are W-2 employees, ensuring they receive benefits and training, which enhances service quality and fosters local community support. The platform integrates various services, enabling residents to request assistance with grocery delivery, home cleaning, and access to exclusive events and virtual classes, all through a single, intuitive interface. Alfred has been recognized as a leader in transforming the real estate industry and has gained media attention for its innovative approach to enhancing the residential living experience.

T She Dingzhi offers a platform for clothes design. Their business enables additional, fully-customizable t-shirts, hoodies, and sweaters to its clients. Through responsible, managed services, subscription cultural apparel, and other means, they are dedicated to assisting businesses in improving their services. It adapts and pursues accuracy and exquisite, repeatedly setting the bar for the sector.

Lamellar Biomedical Ltd. is a biotechnology company based in Bellshill, United Kingdom, established in 2006. The company specializes in the development and commercialization of medical devices and pharmaceuticals centered around Lamellasomes, a synthetic substance that imitates the function of extra-alveolar lamellar bodies. Lamellar Biomedical's innovative products target various respiratory diseases, including cystic fibrosis, and conditions such as radiotherapy-induced xerostomia and dry eye disease. The company’s therapeutic platform leverages anti-infective properties to enhance antibiotic efficacy and protect lung tissues, particularly in complex cases like idiopathic pulmonary fibrosis. Additionally, it facilitates the intracellular delivery of genetic material for pulmonary disease treatment, aiming to provide transformative therapies for severe respiratory conditions. Lamellar Biomedical was previously known as Macrocom (964) Limited before adopting its current name in February 2007.

Source is uniquely positioned to deliver highly liquid products that respond to the challenges and opportunities of the market They partner with some of the world’s largest investment houses and asset managers to create products that either offer exposure to new opportunities in the market or deliver existing strategies more effectively. They work together to ensure all of their products are efficient and transparent. On top of this, they work closely with some of the most well respected trading houses in Europe to ensure that their products are also priced as fairly as possible and are tradable throughout the day. Source is a global investment firm and one of the fastest growing European providers of exchange traded products (ETPs) By focusing on the ever-evolving needs of investors, they have grown assets under management to more than $19 billion (as at 30 July 2014) since their launch in April 2009, and during this time investors have traded more than $575 billion of Source’s products. They offer investors an efficient and transparent way to invest in equities, fixed income and commodities, as well as some alternative asset classes. Their ETPs are open-ended and domiciled in Dublin.

Glide Pharmaceutical Technologies Limited, established in 2001 and based in Abingdon, UK, is a clinical-stage company specializing in the development of solid dose formulations of therapeutics and vaccines. Its core technology, the Solid Dose Injector (SDI) system, aims to enhance patient compliance by facilitating self-administration of long-term therapies without the need for needles. Glide's pipeline includes solid dose formulations of octreotide, teriparatide, anthrax, and influenza vaccines. Additionally, the company is developing a non-invasive diagnostic technology focused on prostate cancer. Formerly known as Caretek Medical, the company changed its name to Glide Pharmaceutical Technologies Limited in 2006.

Vedanta Biosciences, Inc. is a clinical-stage microbiome company based in Cambridge, Massachusetts, focusing on the development of therapies for immune-mediated diseases. Established in 2010, the company specializes in creating immunotherapies utilizing human microbiome-derived bacteria. Its innovative platform includes a collection of defined bacterial consortia, proprietary assays for selecting effective strains, and extensive datasets from human interventional studies. Vedanta Biosciences also possesses capabilities for cGMP-compliant manufacturing, allowing for the production of live bacterial therapies in powder form. This enables healthcare providers to administer oral treatments aimed at addressing autoimmune and inflammatory diseases efficiently, potentially pioneering a new category of therapies based on the human microbiome.

Nexeon Limited is a battery materials and licensing company specializing in the development of silicon anodes for lithium-ion batteries. Founded in 2006 and headquartered in Abingdon, United Kingdom, with an additional office in Yokohama, Japan, Nexeon focuses on providing innovative silicon-based anode materials that enhance energy density and battery capacity. Its technology is applicable across various industries, including consumer electronics, electric vehicles, sustainable energy, aerospace, medical, and defense. By enabling lighter and more efficient batteries, Nexeon's solutions contribute to improved performance and longer lifetimes between charges, supporting the transition to sustainable energy and the achievement of net-zero goals. The company boasts a multidisciplinary technical team with diverse expertise, dedicated to advancing battery technology for a range of consumer and commercial markets.

Jemstep Inc. is a financial technology company based in Los Altos, California, founded in 2008. It specializes in online investment guidance and management services aimed at individual investors and financial advisors. Jemstep offers a range of services, including ratings and analysis of mutual funds and exchange-traded funds (ETFs), as well as tools for asset allocation, portfolio management, and investment research. The company also provides an automated client engagement and onboarding platform, known as Jemstep Advisor Pro, which helps investment advisors enhance their business operations by attracting prospects and improving client service. This platform integrates with various service providers to create a customizable system that supports registered investment advisors and broker-dealers in scaling their businesses effectively.

Gelesis, Inc. is a biotechnology company based in Boston, Massachusetts, focused on developing innovative therapies for gastrointestinal-related chronic diseases, particularly obesity and its associated conditions. Founded in 2006, Gelesis utilizes a mechanobiology technology platform to create first-in-class therapeutics. Its flagship product, PLENITY, is an FDA-cleared, orally administered aid for weight management, comprised of hydrogel particles that expand in the stomach to promote a feeling of fullness and help reduce caloric intake. The company's pipeline also includes potential treatments for non-alcoholic fatty liver disease, type 2 diabetes, and chronic idiopathic constipation, addressing a range of metabolic and digestive health issues.

Lamellar Biomedical Ltd. is a biotechnology company based in Bellshill, United Kingdom, established in 2006. The company specializes in the development and commercialization of medical devices and pharmaceuticals centered around Lamellasomes, a synthetic substance that imitates the function of extra-alveolar lamellar bodies. Lamellar Biomedical's innovative products target various respiratory diseases, including cystic fibrosis, and conditions such as radiotherapy-induced xerostomia and dry eye disease. The company’s therapeutic platform leverages anti-infective properties to enhance antibiotic efficacy and protect lung tissues, particularly in complex cases like idiopathic pulmonary fibrosis. Additionally, it facilitates the intracellular delivery of genetic material for pulmonary disease treatment, aiming to provide transformative therapies for severe respiratory conditions. Lamellar Biomedical was previously known as Macrocom (964) Limited before adopting its current name in February 2007.

Mereo Biopharma, established in London in 2015, specializes in acquiring and advancing late-stage drug candidates from larger pharmaceutical companies. These candidates, often overlooked due to resource constraints, target rare and specialized diseases with significant unmet medical needs. Mereo's strategy involves rapidly progressing these assets through clinical development, either by partnering or divesting them, or directly commercializing them, particularly in orphan disease indications. The company combines operational efficiency with financial resources, leveraging a unique partnership with a leading global CRO, ICON, to conduct comprehensive clinical studies. Mereo's focus is on transforming the lives of patients worldwide by developing innovative medicines that can significantly improve their quality of life.

Akamis Bio is a clinical-stage oncology company dedicated to advancing cancer treatment through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform. The company develops a portfolio of therapeutics specifically targeting solid tumors, aiming to enhance patients' immune responses to recognize and eradicate cancer cells. By harnessing a proprietary intravenously administered viral platform, Akamis Bio focuses on delivering effective gene therapies that address the needs of cancer patients, striving to improve their quality of life and treatment outcomes.

SciFluor Life Sciences, Inc. is a drug discovery company based in Cambridge, Massachusetts, founded in 2011. The company focuses on developing therapeutics for various diseases, with a pipeline that includes small molecule compounds targeting neurology, ophthalmology, fibrosis, and inflammation. Notable products include SF0166, a small molecule integrin antagonist designed for topical treatment of retinal diseases such as age-related macular degeneration and diabetic macular edema, and SF0034, a KCNQ2/3 activator that serves as an anti-epileptic drug for patients with partial-onset epilepsy. SciFluor employs a late-stage fluorination technology, licensed exclusively from Harvard University, which enhances drug properties like metabolic stability, potency, bioavailability, and blood-brain-barrier penetration. This advanced technology allows for the fluorination of a wide range of organic compounds at any stage of development.

Luminex Trading & Analytics is a company that develops an equity trading platform. This platform is designed to offer access to clean, natural block liquidity at significantly lower trading costs. By interacting exclusively with venue-approved participants, the platform ensures low-cost trading with minimal information leakage. This allows traders to execute large block trades with reduced market impact.

SpaceX, officially known as Space Exploration Technologies, is a space transportation company founded in 2002 by Elon Musk and headquartered in Hawthorne, California. The company specializes in the design, manufacture, and launch of advanced rockets and spacecraft, including notable vehicles such as Falcon Heavy, Dragon, and Starship. SpaceX develops a range of technologies including crew and cargo capsules, rocket engines, and avionics, alongside guidance and control software. A key focus of SpaceX is the creation of partially reusable launch vehicles, such as Falcon 1 and Falcon 9, which aim to reduce the costs associated with space travel. By enabling the transport of cargo, humans, and payloads into space, SpaceX seeks to advance the capabilities and affordability of space exploration and travel.

Genomics PLC is a company based in Oxford, United Kingdom, specializing in algorithms and software solutions that focus on cancer, microbes, and rare diseases. Founded in 2014, it aims to revolutionize healthcare through advanced analyses of extensive genomic and phenotypic datasets. By leveraging its expertise, the company provides healthcare providers and governments with tools to enhance patient diagnoses and treatment options. Additionally, Genomics assists pharmaceutical and biotechnology firms in mitigating risks during the drug development process by providing insights into genomic data. Its analytical platform facilitates the investigation of genomic sequences, helping to identify individuals at risk of various diseases. Through these innovations, Genomics seeks to set standards in the use of genomic data, ultimately aiming to improve healthcare outcomes and advance human biology understanding.

Kuur Therapeutics Limited is a biopharmaceutical company focused on developing, manufacturing, and commercializing CAR-NKT cell immunotherapies for cancer treatment. The company is advancing a pipeline of immune cell products, including KUR-501 for neuroblastoma, KUR-502 for hematological malignancies, and KUR-503 for liver cancer. Kuur Therapeutics specializes in engineered off-the-shelf CAR-NKT cell therapies that leverage the natural biology of a specific subset of cytotoxic T cells known as natural killer T cells. This innovative approach aims to provide effective treatment options for a wide range of solid and hematological tumors. The company conducts clinical trials to demonstrate the efficacy of its CAR-NKT cell products, thereby striving to transform cancer care. Founded in 2005 and based in London, Kuur Therapeutics was previously known as Cell Medica Limited before its rebranding in February 2020.

Generator Hostels Ltd., established in 1996 and headquartered in London, specializes in providing budget accommodation for travelers. It owns and operates hostels across Europe and the United States, offering a range of room types from shared to private, along with communal facilities like bars and cafes.

Alkermes, Inc. is an integrated biotechnology company focused on developing, manufacturing, and commercializing medicines for chronic diseases. The company specializes in therapeutic areas such as central nervous system disorders, addiction, diabetes, and autoimmune disorders. Alkermes' key products include VIVITROL, an extended-release formulation of naltrexone used for treating alcohol dependence, and RISPERDAL CONSTA, an injectable medication for schizophrenia and bipolar I disorder. The company operates a research facility in Massachusetts and a commercial manufacturing facility in Ohio. Alkermes employs its proprietary technologies to create pharmaceutical products that address unmet medical needs, and it collaborates with third-party partners to enhance its product development efforts. With a significant presence in the United States, Alkermes also extends its operations to Ireland and other international markets.

Ensurge Micropower specializes in developing ultrathin, flexible, and safe energy storage solutions, primarily for wearable devices and connected sensors. The company utilizes innovative solid-state lithium battery (SSLB) technology, which allows for the creation of powerful, lightweight, and cost-effective rechargeable batteries suitable for a variety of applications. Ensurge operates a state-of-the-art flexible electronics manufacturing facility in Silicon Valley, where it employs patented process technology and materials in conjunction with roll-to-roll production methods to maximize the benefits of its SSLB technology. With corporate headquarters in Oslo and global headquarters in San Jose, Ensurge Micropower is focused on delivering advanced energy storage solutions to both established and emerging markets.

PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.

Infirst Healthcare Ltd. is a UK-based consumer healthcare company established in 2012, specializing in the development of innovative, cocoa-flavored medicines aimed at treating cough and cold symptoms. The company focuses on enhancing well-established over-the-counter and primary care medications through proprietary solutions that can be launched within 12 to 36 months. Infirst Healthcare emerged as a spin-out from SEEK, a privately-owned drug discovery group dedicated to creating breakthrough medicines that significantly improve human health. The company is led by CEO Manfred Scheske, who has a robust background in consumer healthcare, having served as President of GSK's European and North American Consumer Healthcare business, overseeing a diverse portfolio of well-known brands.

Xeros Technology Group plc specializes in developing and commercializing polymer-based technologies aimed at reducing water usage in cleaning processes across various sectors, including fabric and garment manufacturing, as well as industrial and domestic laundry. The company has created innovative products such as XOrbs, which utilize polymer technology to effectively remove dirt and stains with minimal water, and XDrum, designed for fabric and garment manufacturing applications. Additionally, it offers XFiltra, a system that facilitates the easy disposal of collected fibers by de-watering filtered materials. Originating from research by Professor Stephen Burkinshaw at the University of Leeds, Xeros's patented polymer bead cleaning system demonstrates significant potential for cost savings and environmental benefits in commercial laundry and other industries like leather processing and metal cleaning. Based in Rotherham, United Kingdom, Xeros continues to expand its operations in Europe and North America.

Glide Pharmaceutical Technologies Limited, established in 2001 and based in Abingdon, UK, is a clinical-stage company specializing in the development of solid dose formulations of therapeutics and vaccines. Its core technology, the Solid Dose Injector (SDI) system, aims to enhance patient compliance by facilitating self-administration of long-term therapies without the need for needles. Glide's pipeline includes solid dose formulations of octreotide, teriparatide, anthrax, and influenza vaccines. Additionally, the company is developing a non-invasive diagnostic technology focused on prostate cancer. Formerly known as Caretek Medical, the company changed its name to Glide Pharmaceutical Technologies Limited in 2006.

Lamellar Biomedical Ltd. is a biotechnology company based in Bellshill, United Kingdom, established in 2006. The company specializes in the development and commercialization of medical devices and pharmaceuticals centered around Lamellasomes, a synthetic substance that imitates the function of extra-alveolar lamellar bodies. Lamellar Biomedical's innovative products target various respiratory diseases, including cystic fibrosis, and conditions such as radiotherapy-induced xerostomia and dry eye disease. The company’s therapeutic platform leverages anti-infective properties to enhance antibiotic efficacy and protect lung tissues, particularly in complex cases like idiopathic pulmonary fibrosis. Additionally, it facilitates the intracellular delivery of genetic material for pulmonary disease treatment, aiming to provide transformative therapies for severe respiratory conditions. Lamellar Biomedical was previously known as Macrocom (964) Limited before adopting its current name in February 2007.

Kuur Therapeutics Limited is a biopharmaceutical company focused on developing, manufacturing, and commercializing CAR-NKT cell immunotherapies for cancer treatment. The company is advancing a pipeline of immune cell products, including KUR-501 for neuroblastoma, KUR-502 for hematological malignancies, and KUR-503 for liver cancer. Kuur Therapeutics specializes in engineered off-the-shelf CAR-NKT cell therapies that leverage the natural biology of a specific subset of cytotoxic T cells known as natural killer T cells. This innovative approach aims to provide effective treatment options for a wide range of solid and hematological tumors. The company conducts clinical trials to demonstrate the efficacy of its CAR-NKT cell products, thereby striving to transform cancer care. Founded in 2005 and based in London, Kuur Therapeutics was previously known as Cell Medica Limited before its rebranding in February 2020.

Akamis Bio is a clinical-stage oncology company dedicated to advancing cancer treatment through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform. The company develops a portfolio of therapeutics specifically targeting solid tumors, aiming to enhance patients' immune responses to recognize and eradicate cancer cells. By harnessing a proprietary intravenously administered viral platform, Akamis Bio focuses on delivering effective gene therapies that address the needs of cancer patients, striving to improve their quality of life and treatment outcomes.

Oxford Immunotec is a diagnostics company specializing in the development and commercialization of proprietary tests for immunology and infectious diseases. Headquartered in the UK, with operations in the US, the company's core technology, T-SPOT, measures specific T cell responses to inform diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. Its flagship product, T-SPOT.TB, detects active and latent tuberculosis infection, while T-SPOT.CMV monitors cytomegalovirus in transplant recipients. Oxford Immunotec serves independent laboratories, hospital systems, and public and private institutions worldwide.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Spin Memory, Inc. is a technology company specializing in the development of spin-transfer torque magnetoresistive random access memory (STT-MRAM) solutions. Founded in 2007 and headquartered in Fremont, California, the company focuses on addressing the scaling and power challenges associated with conventional memory devices. Spin Memory's innovative MRAM technologies aim to replace on-chip SRAM and various non-volatile memory types in both embedded and stand-alone applications. The company's offerings promise improved performance with faster switching times, reduced power consumption, and enhanced endurance, distinguishing them from traditional memory solutions. Originally established as Spin Transfer Technologies, Inc. through a collaboration between Allied Minds and New York University, Spin Memory is positioned to lead advancements in memory technology with its unique orthogonal spin transfer MRAM approach, which facilitates smaller, more efficient devices without the limitations of endurance and data retention seen in other implementations.

Centrify Corporation specializes in unified identity management software for cloud, mobile, and data center platforms. It operates the Centrify Identity Platform, an enterprise security solution designed to protect against cyber threats and data breaches by securing access points. The company offers Identity-as-a-Service for single sign-on and security across cloud and mobile applications, privileged identity management solutions for least privilege access control, multi-factor authentication services, and a developer program. Its products cater to Fortune 500 companies, financial institutions, retailers, U.S. federal agencies, and other organizations seeking robust identity security for employees, customers, partners, IT admins, and outsourced IT. Founded in 2004, Centrify is headquartered in Santa Clara, California with additional offices in Bellevue, Washington and Murray, Utah.

Nexeon Limited is a battery materials and licensing company specializing in the development of silicon anodes for lithium-ion batteries. Founded in 2006 and headquartered in Abingdon, United Kingdom, with an additional office in Yokohama, Japan, Nexeon focuses on providing innovative silicon-based anode materials that enhance energy density and battery capacity. Its technology is applicable across various industries, including consumer electronics, electric vehicles, sustainable energy, aerospace, medical, and defense. By enabling lighter and more efficient batteries, Nexeon's solutions contribute to improved performance and longer lifetimes between charges, supporting the transition to sustainable energy and the achievement of net-zero goals. The company boasts a multidisciplinary technical team with diverse expertise, dedicated to advancing battery technology for a range of consumer and commercial markets.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.

MaxWest Environmental Systems specializes in the development and operation of waste-to-energy gasification facilities. The company has created a technology that utilizes a gasification and heat integration process to convert various types of waste, including biosolids, agricultural residues, construction and demolition debris, waste plastics, sludge, and wood waste, into renewable energy. By transforming these carbon-based materials into green energy, MaxWest aims to address waste management challenges while contributing to sustainable energy solutions.

Akamis Bio is a clinical-stage oncology company dedicated to advancing cancer treatment through its innovative Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform. The company develops a portfolio of therapeutics specifically targeting solid tumors, aiming to enhance patients' immune responses to recognize and eradicate cancer cells. By harnessing a proprietary intravenously administered viral platform, Akamis Bio focuses on delivering effective gene therapies that address the needs of cancer patients, striving to improve their quality of life and treatment outcomes.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.

Chelsio Communications, Inc. is a technology company based in Sunnyvale, California, specializing in high-performance networking and storage solutions. Founded in 1997, the company develops hardware and software products designed to address the challenges faced by virtualized enterprise data centers, cloud services, and cluster computing environments. Chelsio's offerings include Unified Wire Ethernet network adapter cards, unified storage software, high-performance storage gateways, and unified management software, among others. The company also produces protocol engines and server adapters that facilitate the convergence of networking and storage over Ethernet. Its products are marketed through a network of distributors, integrators, and resellers in both the United States and international markets. Chelsio maintains a design center in Bengaluru, India, to support its innovative solutions.

BaroSense is focused on developing and commercializing innovative medical devices aimed at addressing obesity, a significant healthcare challenge in the United States. The company aims to provide safe, simple, and effective alternatives to surgical treatments for obesity, catering to individuals who require assistance beyond traditional dieting methods and wish to avoid extensive and irreversible surgical options. BaroSense's product offerings include minimally invasive therapeutic procedures and devices, such as a trans-oral endoscopic restrictive implant system, designed to facilitate weight loss in a less invasive manner.

LogLogic is a provider of a scalable log and security intelligence platform designed for enterprises and cloud environments. The company serves over 1,300 customers, offering solutions that enable the collection and analysis of vast amounts of data generated by IT assets. LogLogic's platform equips security, IT operations, and compliance professionals with actionable insights to proactively identify issues, make informed decisions, and ensure compliance with various regulations. By managing over 1,000 petabytes of data, LogLogic enhances network stability and security, giving administrators immediate visibility into network activities and translating raw data into meaningful information.

ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.

NovaSys Health is a prominent provider of managed healthcare services, operating one of the largest health plans in Arkansas. With approximately 11,000 contracted providers in the region and over 4,300 in Arkansas, the company emphasizes strong relationships with healthcare providers. It offers a range of health plans and related services, including customized solutions, provider relations, and eligibility and billing administration, catering to a diverse network of hospitals, physicians, and ancillary providers.

$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.

Touchdown Technologies, Inc. is a manufacturer specializing in advanced Micro-Electro-Mechanical Systems (MEMS) probecards, which are essential for the production wafer testing needs of semiconductor manufacturers. Founded in 2003 and based in Baldwin Park, California, the company offers innovative products such as the ACCU-TORQ probe, a torsional contactor, and GIGA-TORQ probecards specifically designed for DRAM applications. Touchdown Technologies aims to reduce the cost of wafer testing by delivering cutting-edge technologies that enhance the efficiency of highly parallel probecards. The company was previously known as Integrated Micromachines, Inc.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, that specializes in the development and commercialization of respiratory products. The company operates through three main segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, products designed for asthma diagnosis and management, and offers Tudorza and Duaklir for the treatment of COPD. The latter is a fixed-dose combination inhaler that delivers medication for COPD maintenance. Additionally, Circassia is advancing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly to specialists in several countries, including the United States, United Kingdom, China, Italy, and Germany, as well as through international partners. Circassia has a collaboration with AstraZeneca for the promotion of Tudorza and Duaklir, along with U.S. and Chinese commercial rights to LungFit. Founded in 2006, Circassia Group Plc was formerly known as Circassia Pharmaceuticals plc until its name change in May 2020.

Chelsio Communications, Inc. is a technology company based in Sunnyvale, California, specializing in high-performance networking and storage solutions. Founded in 1997, the company develops hardware and software products designed to address the challenges faced by virtualized enterprise data centers, cloud services, and cluster computing environments. Chelsio's offerings include Unified Wire Ethernet network adapter cards, unified storage software, high-performance storage gateways, and unified management software, among others. The company also produces protocol engines and server adapters that facilitate the convergence of networking and storage over Ethernet. Its products are marketed through a network of distributors, integrators, and resellers in both the United States and international markets. Chelsio maintains a design center in Bengaluru, India, to support its innovative solutions.

POINT Biomedical is a privately held pharmaceutical company, founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive two-layer, biodegradable microsphere or biSphereâ„¢. One of the most important features of this technology is the ability to noninvasively trigger the biSpheres to release their contents at sites within the body using externally generated pulses of ultrasound. From this basic platform, POINT is developing a pipeline of products that leverage the unique properties of the biSphere technology in the areas of imaging and therapeutics. POINT has initially focused development of this platform on the assessment of tissue specific blood flow. The lead product, CARDIOsphereâ„¢, is a pharmaceutical agent that will enable cardiologists to perform myocardial perfusion imaging studies in the office setting using ultrasound rather than more expensive and cumbersome nuclear (or radioisotope) techniques

BaroSense is focused on developing and commercializing innovative medical devices aimed at addressing obesity, a significant healthcare challenge in the United States. The company aims to provide safe, simple, and effective alternatives to surgical treatments for obesity, catering to individuals who require assistance beyond traditional dieting methods and wish to avoid extensive and irreversible surgical options. BaroSense's product offerings include minimally invasive therapeutic procedures and devices, such as a trans-oral endoscopic restrictive implant system, designed to facilitate weight loss in a less invasive manner.

Cast Iron Systems, Inc. specializes in providing software-as-a-service integration appliances tailored for large and midsize companies. The company offers the iA3000 application integration appliance, which delivers network computing solutions and preconfigured options for both enterprise and on-demand applications. These solutions enable users to connect with specific applications and facilitate integration processes, particularly for SAP and Oracle systems. In addition to its hardware and software offerings, Cast Iron Systems provides consulting, technical support, and educational services to enhance user experience and operational efficiency. Founded in 2001 and based in Mountain View, California, the company was previously known as IronHide Corporation.

AccountNow is a prominent provider of prepaid card financial solutions, catering to the 40 million consumers in the United States who lack established credit or traditional banking relationships. The company offers an alternative to conventional checking accounts, allowing users to access financial and payment systems through its prepaid Visa and MasterCard cards. AccountNow’s services include online bill payment, card-to-card transfers, and FDIC-insured deposits, enabling customers to deposit paychecks directly and make purchases wherever Visa debit or MasterCard is accepted. The prepaid cards are issued by The Bancorp Bank or MetaBank, ensuring secure and reliable financial services for individuals seeking accessible banking alternatives.

Antenova Ltd is a manufacturer and supplier of standard and custom antenna modules, specializing in radio frequency applications for wireless machine-to-machine (M2M), Internet of Things (IoT), and consumer electronic devices. The company offers a range of products, including gigaNOVA, RADIONOVA, ceriiANT, lamiiANT, flexiiANT, REFLECTOR, and Terminal Antennas, which cater to various applications such as WLAN, Wi-Fi, GPS, and telecoms. In addition to its antenna products, Antenova provides integration, antenna matching and testing, as well as bespoke design services and technical support. Its applications span multiple sectors, including home appliances, automotive, wearables, healthcare, industrial, retail, smart cities, and smart grid. Antenova distributes its products globally through a network of distributors and has operational centers in the United Kingdom, Taiwan, the United States, and China. Founded in 1999, the company is headquartered in Hatfield, United Kingdom.

Centrify Corporation specializes in unified identity management software for cloud, mobile, and data center platforms. It operates the Centrify Identity Platform, an enterprise security solution designed to protect against cyber threats and data breaches by securing access points. The company offers Identity-as-a-Service for single sign-on and security across cloud and mobile applications, privileged identity management solutions for least privilege access control, multi-factor authentication services, and a developer program. Its products cater to Fortune 500 companies, financial institutions, retailers, U.S. federal agencies, and other organizations seeking robust identity security for employees, customers, partners, IT admins, and outsourced IT. Founded in 2004, Centrify is headquartered in Santa Clara, California with additional offices in Bellevue, Washington and Murray, Utah.

Celoxica Limited, established in 1996 and headquartered in Abingdon, UK, with additional offices in Chicago and New York, specializes in providing hardware-accelerated market data access and order execution solutions for the global financial services industry. The company offers accelerated market data line handlers, feed handlers, and order access/execution solutions, catering to trading firms engaged in high-frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica also serves banks executing various strategies across options and equity markets. Operating as a subsidiary of Celoxica Holdings Plc, the company's client base includes advanced trading community members seeking ultra-low latency services.

Cortina Systems is a prominent supplier of intelligent communication solutions, specializing in advanced port processing and connectivity across various market segments, including Core, Metro, Access, and Enterprise. The company focuses on delivering high-speed analog-digital integration through a diverse range of products that cater to the performance, density, and flexibility needs of its customers. By emphasizing collaboration with clients to understand their system requirements, Cortina Systems aims to anticipate future needs and foster the development of new generations of services. Its innovative semiconductor technology enables effective network connectivity and bandwidth delivery from core networks to home networks, facilitating faster market entry and enhancing revenue opportunities for its clients.

LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.

ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.

Cast Iron Systems, Inc. specializes in providing software-as-a-service integration appliances tailored for large and midsize companies. The company offers the iA3000 application integration appliance, which delivers network computing solutions and preconfigured options for both enterprise and on-demand applications. These solutions enable users to connect with specific applications and facilitate integration processes, particularly for SAP and Oracle systems. In addition to its hardware and software offerings, Cast Iron Systems provides consulting, technical support, and educational services to enhance user experience and operational efficiency. Founded in 2001 and based in Mountain View, California, the company was previously known as IronHide Corporation.

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Burnaby, Canada, focused on developing innovative therapeutics for neurological disorders, including rare central nervous system conditions. The company's pipeline includes XEN496 and XEN1101, both Kv7 potassium channel modulators currently in Phase II clinical trials for the treatment of epilepsy. Additionally, Xenon is advancing XEN901, a selective Nav1.6 sodium channel inhibitor, and XEN007, a central nervous system-acting calcium channel modulator, both in Phase I clinical trials. Through its proprietary discovery platform known as Extreme Genetics, Xenon leverages genetic insights from families with severe phenotypes to identify and characterize single-gene defects that may serve as drug targets. The company has also established a collaboration agreement with Neurocrine Biosciences to develop first-in-class treatments for epilepsy, highlighting its commitment to addressing both rare and more prevalent neurological diseases.

Touchdown Technologies, Inc. is a manufacturer specializing in advanced Micro-Electro-Mechanical Systems (MEMS) probecards, which are essential for the production wafer testing needs of semiconductor manufacturers. Founded in 2003 and based in Baldwin Park, California, the company offers innovative products such as the ACCU-TORQ probe, a torsional contactor, and GIGA-TORQ probecards specifically designed for DRAM applications. Touchdown Technologies aims to reduce the cost of wafer testing by delivering cutting-edge technologies that enhance the efficiency of highly parallel probecards. The company was previously known as Integrated Micromachines, Inc.

Celoxica Limited, established in 1996 and headquartered in Abingdon, UK, with additional offices in Chicago and New York, specializes in providing hardware-accelerated market data access and order execution solutions for the global financial services industry. The company offers accelerated market data line handlers, feed handlers, and order access/execution solutions, catering to trading firms engaged in high-frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing. Celoxica also serves banks executing various strategies across options and equity markets. Operating as a subsidiary of Celoxica Holdings Plc, the company's client base includes advanced trading community members seeking ultra-low latency services.

Cortina Systems is a prominent supplier of intelligent communication solutions, specializing in advanced port processing and connectivity across various market segments, including Core, Metro, Access, and Enterprise. The company focuses on delivering high-speed analog-digital integration through a diverse range of products that cater to the performance, density, and flexibility needs of its customers. By emphasizing collaboration with clients to understand their system requirements, Cortina Systems aims to anticipate future needs and foster the development of new generations of services. Its innovative semiconductor technology enables effective network connectivity and bandwidth delivery from core networks to home networks, facilitating faster market entry and enhancing revenue opportunities for its clients.

Centrify Corporation specializes in unified identity management software for cloud, mobile, and data center platforms. It operates the Centrify Identity Platform, an enterprise security solution designed to protect against cyber threats and data breaches by securing access points. The company offers Identity-as-a-Service for single sign-on and security across cloud and mobile applications, privileged identity management solutions for least privilege access control, multi-factor authentication services, and a developer program. Its products cater to Fortune 500 companies, financial institutions, retailers, U.S. federal agencies, and other organizations seeking robust identity security for employees, customers, partners, IT admins, and outsourced IT. Founded in 2004, Centrify is headquartered in Santa Clara, California with additional offices in Bellevue, Washington and Murray, Utah.

ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.

SkyPilot Networks is a prominent provider of carrier-class broadband wireless equipment, catering to service providers, municipalities, and public safety agencies. The company specializes in enabling the rapid deployment of cost-effective network services, including last-mile Internet access, voice over IP, Wi-Fi hotspots, and video surveillance. Utilizing a patented multi-hop point-to-multipoint architecture, SkyPilot's solutions synchronize high-gain directional antennas to enhance reach, reduce interference, and optimize spectral efficiency. This approach results in a highly scalable and reliable broadband wireless network that simplifies design and increases deployment flexibility while significantly lowering equipment and operating costs. SkyPilot's products, such as the SkyPilot Connector Mini and Pro for long-range connectivity, as well as the SkyPilot EMS for network management, support a wide range of wireless applications. The company has successfully delivered its solutions to customers in over 50 countries and is headquartered in Santa Clara, California.

Arcot Systems, Inc. specializes in authentication and digital signing solutions aimed at protecting and verifying the digital identities of cardholders and merchants. Founded in 1997 and headquartered in Sunnyvale, California, with a technology center in Bangalore, India, the company offers a variety of services, including consumer portal protection, FFIEC compliance, identity management, Internet threat protection, SAFE biopharmaceutical compliance, and VPN authentication. Its key products include TransFort for Issuers and Merchants, RiskFort for real-time fraud prevention, WebFort and ArcotID for software-based authentication, A-OK On-Demand for secure authentication processes, and SignFort to streamline document signing and approval. Arcot Systems serves financial institutions, pharmaceutical companies, and e-commerce platforms, helping them combat online fraud and identity theft.

Cast Iron Systems, Inc. specializes in providing software-as-a-service integration appliances tailored for large and midsize companies. The company offers the iA3000 application integration appliance, which delivers network computing solutions and preconfigured options for both enterprise and on-demand applications. These solutions enable users to connect with specific applications and facilitate integration processes, particularly for SAP and Oracle systems. In addition to its hardware and software offerings, Cast Iron Systems provides consulting, technical support, and educational services to enhance user experience and operational efficiency. Founded in 2001 and based in Mountain View, California, the company was previously known as IronHide Corporation.

Genband is a global provider of high-performance IP gateways and session border controllers, which are integral components in fixed and mobile networks worldwide. The company's products facilitate secure communication by evolving and enhancing networks' capabilities.

WhereNet Corporation specializes in wireless solutions for tracking and managing enterprise assets. Founded in 1997 and headquartered in Santa Clara, California, the company offers an integrated wireless infrastructure that supports real-time location, messaging, and telemetry applications. Its key products include WhereLAN, a cellular network of locating access points; WhereLAN LOS, a network of tag transmission receivers; and WhereTag III and IV, low-powered radio frequency transmitters and configurable asset tags, respectively. Additionally, WhereNet provides WhereCall, a wireless messaging system designed for parts replenishment in industrial manufacturing, and WherePort, which enhances the functionality of WhereTags. The company also features the Visibility Software Server, a suite of development tools for integrating its solutions with customer and third-party applications. As of 2007, WhereNet operates as a subsidiary of Zebra Technologies Corp.

$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.

Confluent Photonics Corporation is developing passive and active DWDM optical components for the telecommunications industry based on silicon-on-insulator (SOI) semiconductor fabrication techniques. The use of SOI along with the CMOS fabrication infrastructure developed to process SOI enables cost-effective high volume optical telecom component solutions for the access, metropolitan and long haul telecom markets. The compatibility of Confluent optical designs and manufacturing techniques with CMOS fabrication also provides a pathway for the future integration of optics and electronics on the same telecommunications chip. Current optical telecommunication product technologies and designs result in miniaturized optical lab benches lacking thermal and mechanical robustness. In contrast, Confluent is designing and fabricating Telcordia-compliant optical chip components for the automated manufacture of integrated optical circuits. These components are designed to be insensitive to their environment. Using semiconductor-manufacturing techniques provides built in optical alignment, high volume production and low cost.

LipoScience is a Raleigh, North Carolina-based company specializing in personalized diagnostics through the use of nuclear magnetic resonance (NMR) technology. The company has developed the NMR LipoProfile test, its flagship diagnostic tool, which quantitatively measures low density lipoprotein particles (LDL-P) in blood samples. This test provides physicians and patients with critical information to tailor heart disease risk management effectively. Since its inception, LipoScience has seen significant adoption, with over 8 million NMR LipoProfile tests ordered to date.

VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.

SkyPilot Networks is a prominent provider of carrier-class broadband wireless equipment, catering to service providers, municipalities, and public safety agencies. The company specializes in enabling the rapid deployment of cost-effective network services, including last-mile Internet access, voice over IP, Wi-Fi hotspots, and video surveillance. Utilizing a patented multi-hop point-to-multipoint architecture, SkyPilot's solutions synchronize high-gain directional antennas to enhance reach, reduce interference, and optimize spectral efficiency. This approach results in a highly scalable and reliable broadband wireless network that simplifies design and increases deployment flexibility while significantly lowering equipment and operating costs. SkyPilot's products, such as the SkyPilot Connector Mini and Pro for long-range connectivity, as well as the SkyPilot EMS for network management, support a wide range of wireless applications. The company has successfully delivered its solutions to customers in over 50 countries and is headquartered in Santa Clara, California.

StarVox Communications is a provider of wholesale and retail voice services, specializing in both traditional voice and enhanced Voice over Internet Protocol (VoIP) offerings. The company operates a domestic VoIP network featuring multiple points of presence, enabling reliable and cost-effective connectivity for established and emerging carriers. StarVox integrates its software with industry-standard platforms, including those from major providers like Hewlett Packard and Cisco, to deliver a comprehensive, factory-integrated IP telephony solution. This solution not only unifies voice and written communication through a desktop application but also offers real-time reporting and statistics, enhancing the overall service experience for users.